Last checked at 31 Oct 2023 07:00
31 October 2023
Assura plc
Notice of Interim Results
Assura plc ("the Company"), the UK's leading primary care property investor and developer will announce results for the six months ended 30 September 2023 on Thursday 16 November 2023.
A presentation for analysts and investors, immediately followed by a Q&A with members of the senior management team, can be viewed at 10.00 am GMT at the following link:
https://brrmedia.news/AGR_IR23
- Ends -
For more information, please contact:
Assura plc David Purcell, Investor Relations Director | Tel: 0161 515 2043 Email: Investor@assura.co.uk |
Finsbury Glover Hering Gordon Simpson | Tel: 0207 251 3801 Email: Assura@Finsbury.com |
Notes to Editors
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.
Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association